Paratyphoid fever medical therapy: Difference between revisions
No edit summary |
|||
| Line 1: | Line 1: | ||
{{Paratyphoid fever}} | {{EH}}{{Paratyphoid fever}} | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
Revision as of 17:19, 3 February 2012
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
|
Paratyphoid fever Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Paratyphoid fever medical therapy On the Web |
|
American Roentgen Ray Society Images of Paratyphoid fever medical therapy |
|
Risk calculators and risk factors for Paratyphoid fever medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [2]
Overview
Empiric treatment in most parts of the world would use a fluoroquinolone, most often ciprofloxacin. However, resistance to fluoroquinolones is highest in the Indian subcontinent and increasing in other areas. Injectable third-generation cephalosporins are often the empiric drug of choice when the possibility of fluoroquinolone resistance is high. Patients treated with an appropriate antibiotic may still require 3–5 days to defervesce completely, although the height of the fever decreases each day. Patients may actually feel worse when the fever starts to go away. If fever does not subside within 5 days, alternative antimicrobial agents or other foci of infection should be considered.